Supporting a pathological role of S100A11 upregulation in NAFLD, S100A11 overexpression in mice livers (by in vivo adenoviral transduction of hepatotropic associated-adeno viruses encoding S100A11 DNA, AAV8) fostered steatosis development [110]. The gene discussed is S100A11; the disease is metabolic dysfunction-associated steatotic liver disease.